Cargando…
Cancer associated-fibroblast-derived exosomes in cancer progression
To identify novel cancer therapies, the tumor microenvironment (TME) has received a lot of attention in recent years in particular with the advent of clinical successes achieved by targeting immune checkpoint inhibitors (ICIs). The TME consists of multiple cell types that are embedded in the extrace...
Autores principales: | Li, Chao, Teixeira, Adilson Fonseca, Zhu, Hong-Jian, ten Dijke, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8638446/ https://www.ncbi.nlm.nih.gov/pubmed/34852849 http://dx.doi.org/10.1186/s12943-021-01463-y |
Ejemplares similares
-
On-Target Anti-TGF-β Therapies Are Not Succeeding in Clinical Cancer Treatments: What Are Remaining Challenges?
por: Teixeira, Adilson Fonseca, et al.
Publicado: (2020) -
Cancer-associated fibroblast-derived Gremlin 1 promotes breast cancer progression
por: Ren, Jiang, et al.
Publicado: (2019) -
Exosomal microRNAs derived from colorectal cancer-associated fibroblasts: role in driving cancer progression
por: Bhome, Rahul, et al.
Publicado: (2017) -
E3 Ubiquitin Ligases: Key Regulators of TGFβ Signaling in Cancer Progression
por: Sinha, Abhishek, et al.
Publicado: (2021) -
Emerging Role of Cancer-Associated Fibroblasts-Derived Exosomes in Tumorigenesis
por: Peng, Lushan, et al.
Publicado: (2022)